Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals

$4.40 0.06 (1.38%)

High $4.46	Low $4.23	Trades 1,020	Turnover $2,463,536	Volume 565,229
30 June 2023 at 4:10pm

Market Cap (23-Oct) $200,632,672 (439th)	Close (30-Jun) $4.40 0 (0%)	Volume (30-Jun) 565,229	Shortsold (19-Oct) 1,901,227 (2.32%) (144th)
52w High $6.25	52w Low $2.04	P/E 263.16	EPS 0.31

Short Interest

ASIC data, 19 Oct 2026

% Shorted

2.32% 0.02

vs 2.30% prior report

Most Shorted Rank

144th

of 703 shorted ASX stocks

Peak Short

13.53%

May 2017

Days to Cover

10.4

at 50d avg vol

View full short position history →

	Subject
	MYX MYX Ann: Update - Notification of buy-back - MYX
	1 (current) 2 3
	MYX MYX Ann: Update - Notification of buy-back - MYX
	MYX MYX Ann: Update on sale of US retail generics portfolio
	MYX MYX Ann: Change of Director's Interest Notice
	MYX MYX Ann: Notification of buy-back - MYX
	MYX MYX Ann: Change of Director's Interest Notice
	MYX MYX Ann: Change of Director's Interest Notice
	MYX MYX Ann: Update on convertible note arrangements with Rubric Capital
	MYX MYX Ann: Change in substantial holding
	MYX MYX Ann: Becoming a substantial holder
	MYX MYX Ann: Return of Capital - MYX (cancellation)
	MYX MYX Ann: Mayne Pharma announces cancellation of capital return
	MYX MYX Ann: 2023 Half Year Investor Presentation
	MYX MYX Ann: 2022 Half Year Media Release
	MYX MYX Ann: Half Yearly Report and Accounts
	MYX MYX Ann: Mayne Pharma announces sale of US retail generics business
	MYX MYX Ann: Trading Halt
	MYX MYX Ann: Pause in Trading
	MYX MYX Ann: MYX signs license & supply agreement for generic Oracea
	MYX MYX Ann: MYX announces US launch of Diltiazem ER and Doryx MPC 60mg
	MYX MYX Ann: Mayne Pharma to restate US dermatology net revenue for FY22
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: Update - Notification of buy-back - MYX
	MYX MYX Ann: US launch of HALOETTE, a generic version of NUVARING
	MYX MYX Ann: Return of Capital - MYX (updated)
	MYX MYX Ann: JP Morgan Healthcare Conference Presentation
	MYX MYX Ann: Mayne Pharma provides update on capital management timeline
	MYX MYX Ann: Notification of buy-back - MYX
	MYX MYX Ann: Notification regarding unquoted securities - MYX
	MYX MYX Ann: MYX completes TherapeuticsMD product licensing transaction
	MYX MYX Ann: Section 708A cleansing notice
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: Proposed issue of securities - MYX
	MYX MYX Ann: MYX signs license agreement for women's health products
	MYX MYX Ann: Results of Meeting
	MYX MYX Ann: Chairman's Address to Shareholders
	MYX MYX Ann: AGM presentation and business and trading update
	MYX MYX Ann: Return of Capital - MYX
	MYX MYX Ann: Dividend/Distribution - MYX
	MYX MYX Ann: Consolidation/Split - MYX
	MYX MYX Ann: 2022 AGM Notice of meeting and shareholder pack
	MYX MYX Ann: Mayne Pharma capital management update
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: Annual Report to shareholders
	MYX MYX Ann: 2022 Corporate Governance Statement and Appendix 4G
	MYX MYX Ann: Mayne Pharma completes sale of Metrics Contract Services
	MYX MYX Ann: Initial Director's Interest Notice
	MYX MYX Ann: Final Director's Interest Notice x2
	MYX MYX Ann: Mayne Pharma appoints new CEO
	MYX MYX Ann: Notification regarding unquoted securities - MYX

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
23-Oct	$2.45	103,598	-0.04 (1.61%)
22-Oct	$2.49	119,543	-0.05 (1.97%)
21-Oct	$2.54	123,158	0.00 (0.00%)
20-Oct	$2.54	120,955	-0.01 (0.39%)
19-Oct	$2.55	125,283	+0.03 (1.19%)
16-Oct	$2.52	103,574	+0.03 (1.20%)
15-Oct	$2.49	158,899	-0.20 (7.43%)
14-Oct	$2.69	131,068	+0.15 (5.91%)
13-Oct	$2.54	119,710	+0.02 (0.79%)
12-Oct	$2.52	216,511	-0.14 (5.26%)
09-Oct	$2.66	87,200	-0.09 (3.27%)
08-Oct	$2.75	129,521	-0.08 (2.83%)
07-Oct	$2.83	48,100	0.00 (0.00%)
06-Oct	$2.83	101,971	+0.01 (0.35%)
05-Oct	$2.82	45,764	-0.03 (1.05%)
5 up, 8 down, and 2 flat days

Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Mayne Pharma Group Health Care Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals